| Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine T Vesikari, J Wysocki, B Chevallier, A Karvonen, H Czajka, JP Arsène, ... The Pediatric infectious disease journal 28 (4), S66-S76, 2009 | 326 | 2009 |
| Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years TF Schwarz, M Spaczynski, A Schneider, J Wysocki, A Galaj, P Perona, ... Vaccine 27 (4), 581-587, 2009 | 208 | 2009 |
| Studies on the meningococcal polysaccharides: I. Composition and chemical properties of the group A polysaccharide TY Liu, EC Gotschlich, EK Jonssen, JR Wysocki Journal of Biological Chemistry 246 (9), 2849-2858, 1971 | 180 | 1971 |
| Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo … PC Richmond, HS Marshall, MD Nissen, Q Jiang, KU Jansen, ... The Lancet infectious diseases 12 (8), 597-607, 2012 | 175 | 2012 |
| The strategies to support the COVID-19 vaccination with evidence-based communication and tackling misinformation P Rzymski, L Borkowski, M Drąg, R Flisiak, J Jemielity, J Krajewski, ... Vaccines 9 (2), 109, 2021 | 169 | 2021 |
| The perception and attitudes toward COVID-19 vaccines: A cross-sectional study in Poland P Rzymski, J Zeyland, B Poniedziałek, I Małecka, J Wysocki Vaccines 9 (4), 382, 2021 | 147 | 2021 |
| Randomized, placebo‐controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B KF Murray, L Szenborn, J Wysocki, S Rossi, AC Corsa, P Dinh, ... Hepatology 56 (6), 2018-2026, 2012 | 143 | 2012 |
| Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis … J Wysocki, JC Tejedor, D Grunert, R Konior, J Garcia-Sicilia, M Knuf, ... The Pediatric infectious disease journal 28 (4), S77-S88, 2009 | 123 | 2009 |
| Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind … R Prymula, MR Bergsaker, S Esposito, L Gothefors, S Man, N Snegova, ... The Lancet 383 (9925), 1313-1324, 2014 | 113 | 2014 |
| Meningococcal serogroup B bivalent rLP2086 vaccine elicits broad and robust serum bactericidal responses in healthy adolescents T Vesikari, L Østergaard, J Diez-Domingo, J Wysocki, CE Flodmark, ... Journal of the Pediatric Infectious Diseases Society 5 (2), 152-160, 2016 | 78 | 2016 |
| Expression of cytokines (TNF-α, IL-1α, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients A Kasprzak, M Zabel, W Biczysko, J Wysocki, A Adamek, R Spachacz, ... Journal of Histochemistry & Cytochemistry 52 (1), 29-38, 2004 | 77 | 2004 |
| Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients J Nowak, D Januszkiewicz, K Lewandowski, K Nowicka-Kujawska, ... European journal of gastroenterology & hepatology 15 (1), 75-80, 2003 | 72 | 2003 |
| Ten‐year immune persistence and safety of the HPV‐16/18 AS 04‐adjuvanted vaccine in females vaccinated at 15–55 years of age TF Schwarz, A Galaj, M Spaczynski, J Wysocki, AM Kaufmann, S Poncelet, ... Cancer medicine 6 (11), 2723-2731, 2017 | 70 | 2017 |
| Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years TF Schwarz, M Spaczynski, A Schneider, J Wysocki, A Galaj, K Schulze, ... Human vaccines 7 (9), 958-965, 2011 | 64 | 2011 |
| 13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants F Martinón-Torres, H Czajka, KJ Center, J Wysocki, E Majda-Stanislawska, ... Pediatrics 135 (4), e876-e886, 2015 | 55 | 2015 |
| Immunogenicity, safety, and tolerability of bivalent rLP2086 meningococcal group B vaccine administered concomitantly with diphtheria, tetanus, and acellular pertussis and … T Vesikari, J Wysocki, J Beeslaar, J Eiden, Q Jiang, KU Jansen, TR Jones, ... Journal of the Pediatric Infectious Diseases Society 5 (2), 180-187, 2016 | 52 | 2016 |
| A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations J Wysocki, KJ Center, J Brzostek, E Majda-Stanislawska, H Szymanski, ... Vaccine 35 (15), 1926-1935, 2017 | 50 | 2017 |
| Persistence of immune responses to the HPV‐16/18 AS 04‐adjuvanted vaccine in women aged 15–55 years and first‐time modelling of antibody responses in mature women: results from … T Schwarz, M Spaczynski, A Kaufmann, J Wysocki, A Gałaj, K Schulze, ... BJOG: An International Journal of Obstetrics & Gynaecology 122 (1), 107-118, 2015 | 50 | 2015 |
| Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection A Szkaradkiewicz, A Jopek, J Wysocki Antiviral research 66 (1), 23-27, 2005 | 49 | 2005 |
| Don’t forget how severe varicella can be—complications of varicella in children in a defined Polish population E Gowin, J Wysocki, M Michalak International Journal of Infectious Diseases 17 (7), e485-e489, 2013 | 48 | 2013 |
